iShares U.S. Healthcare ETF (IYH) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

iShares U.S. Healthcare ETF (IYH) Financial Services Profile

iShares U.S. Healthcare ETF (IYH) offers diversified exposure to U.S. healthcare equities, including pharmaceuticals, biotechnology, and healthcare services, making it a strategic choice for investors seeking to capitalize on the growth of the healthcare sector.

What Is the Investment Thesis for IYH?

The iShares U.S. Healthcare ETF (IYH) presents a compelling investment thesis driven by the robust growth of the healthcare sector, projected to expand at a CAGR of 7.9% from 2021 to 2028. The ETF's focus on U.S. healthcare equities allows investors to capitalize on advancements in pharmaceuticals and biotechnology, which are expected to see increased funding and innovation. Furthermore, the aging population and rising healthcare expenditures are anticipated to drive demand for healthcare services, thereby benefiting the underlying companies in the ETF. With a market cap of $3.81B, IYH is well-positioned to leverage these growth catalysts. However, investors should remain cautious of ongoing regulatory scrutiny and potential policy changes that could impact profitability across the sector. Monitoring healthcare legislation will be critical for assessing the ETF's performance and the viability of its holdings.

Based on FMP financials and quantitative analysis

IYH Key Highlights

Market capitalization of $3.81B reflects significant investor interest and trust in the ETF.

• Beta of 0.57 indicates lower volatility compared to the broader market, appealing to risk-averse investors.
• Focus on U.S. healthcare equities provides exposure to a sector projected to grow at a CAGR of 7.9% through 2028.
• No dividend yield, emphasizing a strategy focused on capital appreciation rather than income generation.
• Diversified holdings across pharmaceuticals, biotechnology, and healthcare services mitigate sector-specific risks.

Who Are IYH's Competitors?

IYH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IYH's Key Strengths?

Strong market capitalization of $3.81B indicates investor confidence.

• Diversified exposure to various healthcare sectors mitigates risks.
• Managed by BlackRock, ensuring robust management and operational expertise.

What Are IYH's Weaknesses?

No dividend yield may deter income-focused investors.

• Exposure to regulatory changes that could impact healthcare profitability.
• Market volatility can affect ETF performance despite its defensive nature.

What Are the Key Risks for IYH?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

What Are the Growth Opportunities for IYH?

• Growth opportunity 1: The U.S. healthcare market is projected to grow significantly, with estimates suggesting it will reach $11.9 trillion by 2027. This growth is driven by an aging population and increased healthcare spending. IYH's focus on U.S. healthcare equities positions it to benefit from this expanding market, as more investors seek exposure to this essential sector.
• Growth opportunity 2: Advances in biotechnology and pharmaceuticals are expected to drive innovation and growth within the healthcare sector. With substantial investments in research and development, companies within IYH's portfolio are likely to introduce breakthrough therapies and treatments, enhancing their profitability and market share. This trend is expected to accelerate over the next five years, further solidifying IYH's value proposition.
• Growth opportunity 3: The ongoing digital transformation in healthcare, including telemedicine and health tech innovations, is reshaping the industry. As healthcare providers increasingly adopt technology to improve patient outcomes and operational efficiency, companies in IYH's portfolio stand to gain from these trends. The digital health market is projected to grow at a CAGR of 27.7% from 2021 to 2028, presenting a significant opportunity for IYH.
• Growth opportunity 4: Legislative changes aimed at improving healthcare access and affordability could enhance the performance of companies within IYH. As policymakers focus on expanding healthcare coverage and reducing costs, firms in the ETF's portfolio may see increased demand for their products and services. This dynamic is expected to evolve over the next few years, creating a favorable environment for IYH.
• Growth opportunity 5: The increasing global focus on health and wellness, particularly post-pandemic, is driving demand for healthcare services and products. IYH's diversified exposure to various healthcare sectors positions it to capitalize on this trend, as consumers and governments prioritize health investments. The market for health and wellness is expected to grow significantly, providing a tailwind for IYH's holdings.

What Threats Does IYH Face?

• Ongoing regulatory scrutiny and potential policy changes affecting the healthcare sector.
• Economic downturns may impact investor sentiment toward equities.
• Competition from other healthcare ETFs and investment vehicles.

What Are IYH's Competitive Advantages?

• Managed by BlackRock, which has a strong reputation and extensive resources in asset management.
• Diversified holdings across multiple healthcare sub-sectors reduce exposure to individual company risks.
• The ETF's defensive nature during economic downturns attracts risk-averse investors.

What Does IYH Do?

The iShares U.S. Healthcare ETF (IYH) was launched to provide investors with a means to gain exposure to the performance of U.S. companies within the healthcare sector. It is managed by BlackRock, one of the largest asset management firms globally, which has a strong reputation for its ETFs. The fund aims to replicate the investment performance of an index that includes a diverse range of healthcare-related stocks, including those involved in pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. As of now, the ETF has a market capitalization of approximately $3.15 billion, reflecting its substantial presence in the financial markets. The ETF does not pay dividends, focusing instead on capital appreciation, which aligns with the growth potential of the healthcare sector. IYH's defensive nature during economic downturns is a potential strength, as healthcare tends to remain resilient in challenging economic climates. The ETF's holdings are diversified across various sub-sectors, which helps mitigate risks associated with individual companies. As healthcare continues to evolve with advancements in technology and increasing demand for healthcare services, IYH positions itself to benefit from these trends, making it an integral part of many investors' portfolios looking to tap into the growth of the healthcare industry.

What Products and Services Does IYH Offer?

• iShares U.S. Healthcare ETF (IYH) provides investors with exposure to U.S. healthcare equities.
• The ETF mirrors the performance of a benchmark index comprised of healthcare companies.
• IYH includes stocks from various sub-sectors such as pharmaceuticals, biotechnology, and healthcare services.
• The fund is managed by BlackRock, a leading global asset management firm.
• IYH focuses on capital appreciation rather than income generation, as it does not pay dividends.
• The ETF aims to offer diversified access to the healthcare sector, minimizing individual stock risk.

How Does IYH Make Money?

• IYH generates revenue through management fees charged to investors.
• The ETF's performance is tied to the underlying healthcare equities it holds.
• IYH aims for capital appreciation by tracking the performance of a healthcare index.
• The fund's diversified approach helps mitigate risks associated with individual stock performance.

What Industry Does IYH Operate In?

The asset management industry, particularly in the context of ETFs, has seen substantial growth, with healthcare ETFs gaining traction due to the sector's resilience and growth potential. The global healthcare market is projected to reach $11.9 trillion by 2027, driven by factors such as technological advancements, an aging population, and increasing healthcare spending. The competitive landscape includes various ETFs, with IYH distinguishing itself through its focused investment strategy on U.S. healthcare equities. This positioning allows IYH to capture the growth opportunities within a sector that is increasingly vital to the economy and society.

Who Are IYH's Key Customers?

• Institutional investors seeking exposure to the healthcare sector.
• Retail investors looking for diversified investment options in healthcare.
• Financial advisors and wealth managers incorporating healthcare ETFs into client portfolios.

How iShares U.S. Healthcare ETF Is Valued

iShares U.S. Healthcare ETF carries a market capitalization of $3.81B, placing it in the mid-cap category. Relative to its peer group, IYH's quantitative score of 46/100 is below the peer average of 69/100.

Return on equity for iShares U.S. Healthcare ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. IYH trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

iShares U.S. Healthcare ETF's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 40.92 places it in the safe zone, indicating low near-term bankruptcy risk.

IYH Financials

IYH Latest News

IYH Analyst Consensus

IYH MoonshotScore

IYH Financial Services Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources